Skip to main content
. 2011 Aug 1;38(8):4846–4857. doi: 10.1118/1.3611042

Figure 8.

Figure 8

PDD from the top benchmarking test with a 97.3% pass rate. (A) and (C) Transverse and coronal views of DLOS∕PRESAGE measured dose distributions with normalized dose colormap in % maximum dose. (B) and (D) Corresponding measured and calculated isodose-overlay maps.